This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Cilian Ag. Active years: 2010-2012.
Company Filing History:
Years Active: 2010-2012
Title: Thomas Weide: Innovator in Ciliate Cell Research
Introduction
Thomas Weide is a notable inventor based in Altenberge, Germany. He has made significant contributions to the field of biotechnology, particularly in the study of ciliate cells. With a total of 2 patents, his work focuses on innovative methods that enhance our understanding of cellular processes.
Latest Patents
Weide's latest patents include a method for producing a ciliate cell with reduced or essentially no dihydrofolate reductase (DHFR) activity or reduced or essentially no thymidylate synthase (TS) activity. This method is crucial for understanding the deficiencies in ciliate tetrahymena. Another patent involves a method that characterizes samples having units by monitoring fluctuating intensities of radiation emitted, scattered, and/or reflected by the units. This method includes steps such as measuring photon counts and determining specific brightness functions.
Career Highlights
Thomas Weide is currently associated with Cilian AG, where he applies his expertise in biotechnology. His innovative approaches have positioned him as a key figure in his field, contributing to advancements in ciliate cell research.
Collaborations
Weide collaborates with notable colleagues, including Marcus Hartmann and Lutz Herrmann. Their combined efforts enhance the research and development initiatives at Cilian AG.
Conclusion
Thomas Weide's contributions to biotechnology, particularly in ciliate cell research, highlight his role as an influential inventor. His patents and collaborations reflect a commitment to advancing scientific knowledge and innovation.